Summary

Asia-Pacific veterinary medicine market is expected to reach USD 19.42 billion by 2032 from USD 10.28 billion in 2024, growing at a CAGR of 8.3% in the forecast period of 2025 to 2032.
Market Segmentation:
Asia-Pacific Veterinary Medicine Market, By Type (Therapeutics and Diagnostics), Application (Bacterial Diseases, Canine Atopic Dermatitis, Heminthes Infection, Animal Cancer, Foot and Mouth Disease, Autoimmune Diseases, Bluetongue, and Others), Animal Type (Companion Animals and Production Animal), End User (Veterinary Hospitals, Veterinary Clinics, Animal And Veterinary Farms, Reference Laboratories, Academic And Research Institute, Point-Of-Care Testing/In-House Testing, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others), Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Philippines, and Rest of Asia-Pacific) - Industry Trends & Forecast To 2032
Overview of the Asia-Pacific Veterinary Medicine Market are:

Driver

• Increasing Pet Ownership Boosts Demand For Veterinary Services

Restraint

• High Veterinary Care Costs Limit Market Accessibility

Opportunity

• Increasing Number of Animals Leading to The Demand Of Veterinary Medicine

Market Players:

The key market players for Asia-Pacific veterinary medicine market are listed below:

• Zoetis Services LLC
• Merck & Co., Inc.
• Elanco or its affiliates
• C.H. Boehringer Ingelheim International GmbH
• IDEXX LABORATORIES, INC
• AB Science
• AdvaCare Pharma
• ALMAX IMAGING srl
• Anivive
• BIOMÉRIEUX
• Bionote USA Inc.
• Bio-Rad Laboratories, Inc.
• CANON MEDICAL SYSTEMS EUROPE B.V.
• Cargill, Incorporated
• Ceva
• CureLab Oncology
• Dechra Pharmaceuticals Limited
• Narang Medical Limited
• Neogen Corporation
• NIPPON ZENYAKU KOGYO CO., LTD.
• Demeditec Diagnostics GmbH
• DHN International
• Diagnostic Imaging Systems
• ESAOTE SPA
• Eurofins Scientific
• Evonik Industries AG
• FUJIFILM Holdings Corporation
• Gold Standard Diagnostics
• Hallmarq Veterinary Imaging
• Hebei Veyong Pharmaceutical Co., Ltd.
• IBIS S.R.L.
• Virbac
• VMRD, Inc.
• Heska Corporation
• Karyopharm
• Meridian Bioscience, Inc.
• VetDC
• Novavive Inc.
• Nutreco
• PLANMECA OΥ
• Randox Laboratories Ltd.
• RINGPU BIOLOGY Co., Ltd.
• Shenzhen SONT U Medical Imaging Equipment Co., Ltd
• Torigen Pharmaceuticals Inc.
• Thermo Fisher Scientific Inc.
• Vetoquinol

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 73
1.1 OBJECTIVES OF THE STUDY 73
1.2 MARKET DEFINITION 73
1.3 OVERVIEW OF THE ASIA-PACIFIC VETERINARY MEDICINE MARKET 73
1.4 CURRENCY AND PRICING 76
1.5 LIMITATIONS 76
1.6 MARKETS COVERED 76
2 MARKET SEGMENTATION 84
2.1 MARKETS COVERED 84
2.2 GEOGRAPHICAL SCOPE 85
2.3 YEARS CONSIDERED FOR THE STUDY 86
2.4 DBMR TRIPOD DATA VALIDATION MODEL 87
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 90
2.6 MULTIVARIATE MODELLING 91
2.7 DBMR MARKET POSITION GRID 92
2.8 MARKET END USER COVERAGE GRID 93
2.9 VENDOR SHARE ANALYSIS 94
2.10 SECONDARY SOURCES 95
2.11 ASSUMPTIONS 95
3 EXECUTIVE SUMMARY 96
4 PREMIUM INSIGHTS 105
4.1 PESTAL ANALYSIS 107
4.2 PORTERS FIVE FORCES ANALYSIS 108
4.3 PIPELINE ANALYSIS 109
4.4 TOP ENTITIES BASED ON R&D GLANCE FOR VETERINARY MEDICINE MARKET 110
4.5 EPIDEMIOLOGY 111
5 ASIA-PACIFIC VETERINARY MEDICINE MARKET: REGULATIONS 112
6 MARKET OVERVIEW 114
6.1 DRIVERS 116
6.1.1 INCREASING PET OWNERSHIP BOOSTS DEMAND FOR VETERINARY SERVICES 116
6.1.2 RISING ANIMAL DISEASES DRIVE NEED FOR ADVANCED VETERINARY CARE 117
6.1.3 VETERINARY MEDICINE ADVANCES IMPROVE DIAGNOSIS AND TREATMENT OPTIONS 117
6.1.4 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS INCREASES VETERINARY NEEDS 118
6.2 RESTRAINTS 120
6.2.1 HIGH VETERINARY CARE COSTS LIMIT MARKET ACCESSIBILITY 120
6.2.2 LACK OF AWARENESS ABOUT ANIMAL HEALTH LIMITS PROPER VETERINARY CARE ACCESS 120
6.3 OPPORTUNITIES 122
6.3.1 INCREASING NUMBER OF ANIMALS LEADING TO THE DEMAND OF VETERINARY MEDICINE 122
6.3.2 GROWTH IN ANIMAL HEALTH BIOTECHNOLOGY 122
6.3.3 GROWTH IN DEMAND FOR NUTRITIONAL SUPPLEMENTS 123
6.4 CHALLENGES 124
6.4.1 CHALLENGES OF REGULATORY COMPLIANCE AND COMPLEXITY 124
6.4.2 SHORTAGE OF VETERINARY PROFESSIONALS 124
7 ASIA-PACIFIC VETERINARY MEDICINE MARKET, BY TYPE 126
7.1 OVERVIEW 127
7.2 THERAPEUTICS 130
7.2.1 PHARMACEUTICALS 132
7.2.1.1 ANTIBIOTICS 133
7.2.1.1.1 TETRACYCLINE 133
7.2.1.1.2 PENICILLINS 133
7.2.1.1.3 MACROLIDES 133
7.2.1.1.4 AMINOGLYCOSIDES 133
7.2.1.1.5 LINCOSAMIDES 133
7.2.1.1.6 COLISTIN 133
7.2.1.1.7 OTHERS 133
7.2.1.2 PARASITICIDES 134
7.2.1.2.1 BENZIMIDAZOLES 134
7.2.1.2.2 MACROCYCLIC LACTONES 134
7.2.1.2.3 PYRETHROIDS 134
7.2.1.2.4 AMPROLIUM 134
7.2.1.2.5 NITROIMIDAZOLES 134
7.2.1.2.6 PIPERAZINE 134
7.2.1.2.7 OTHERS 134
7.2.1.3 ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) 135
7.2.1.3.1 CARPROFEN 135
7.2.1.3.2 MELOXICAM 135
7.2.1.3.3 PHENYLBUTAZONE 135
7.2.1.3.4 ACETAMINOPHEN 135
7.2.1.3.5 FIROCOXIB 135
7.2.1.3.6 DERACOXIB 135
7.2.1.3.7 OTHERS 135
7.2.1.4 ANTIHISTAMINES 136
7.2.1.4.1 CETIRIZINE 136
7.2.1.4.2 BROMPHENIRAMINE 136
7.2.1.4.3 DIPHENHYDRAMINE 136
7.2.1.4.4 TERFENADINE 136
7.2.1.4.5 TRIMEPRAZINE 136
7.2.1.4.6 OTHERS 136
7.2.1.5 CORTICOSTEROIDS 137
7.2.1.5.1 DEXAMETHASONE 137
7.2.1.5.2 PREDNISOLONE 137
7.2.1.5.3 PREDNISONE 137
7.2.1.5.4 OTHERS 137
7.2.1.6 ANTIBLOAT 138
7.2.1.6.1 DOCUSATE 138
7.2.1.6.2 SIMETHICONE 138
7.2.1.6.3 OTHERS 138
7.2.1.7 HORMONAL 139
7.2.1.7.1 EQUINE CHORIONIC GONADOTROPIN 139
7.2.1.7.2 CLOPROSTENOL 139
7.2.1.7.3 OXYTOCIN 139
7.2.1.7.4 OTHERS 139
7.2.1.8 OPIOIDS 140
7.2.1.8.1 MU AGONISTS 140
7.2.1.8.1.1 METHADONE 141
7.2.1.8.1.2 MEPERIDINE 141
7.2.1.8.1.3 MORPHINE 141
7.2.1.8.1.4 OXYMORPHONE 141
7.2.1.8.1.5 OTHERS 141
7.2.1.8.2 PARTIAL MU AGONIST 142
7.2.1.8.2.1 BUPRENORPHINE 142
7.2.1.8.2.2 OTHERS 142
7.2.1.8.3 KAPPA AGONIST-MU ANTAGONIST 142
7.2.1.8.3.1 BUTORPHANOL 142
7.2.1.8.3.2 OTHERS 142
7.2.1.9 OTHERS 143
7.2.1.10 PHARMACEUTICALS BY DRUG TYPE 143
7.2.1.10.1 BRANDED 143
7.2.1.10.2 GENERIC 143
7.2.1.11 PHARMACEUTICALS BY PRESCRIPTION MODE 143
7.2.1.11.1 PRESCRIPTION BASED 143
7.2.1.11.2 OVER THE COUNTER 143
7.2.1.12 PHARMACEUTICALS BY ROUTE OF ADMINISTRATION, 144
7.2.1.12.1 ORAL 144
7.2.1.12.1.1 TABLETS 145
7.2.1.12.1.2 SOLUTIONS 145
7.2.1.12.1.3 POWDER 145
7.2.1.12.1.4 OTHERS 145
7.2.1.12.2 PARENTAL 145
7.2.1.12.2.1 INTRAVENOUS 145
7.2.1.12.2.2 SUBCUTANEOUS 145
7.2.1.12.2.3 OTHERS 145
7.2.1.12.3 TOPICAL 145
7.2.1.12.4 OTHERS 145
7.2.2 VACCINES 146
7.2.2.1 LIVE ATTENUATED VACCINES 146
7.2.2.2 TOXOID VACCINES 146
7.2.2.3 RECOMBINANT VACCINES 146
7.2.2.4 INACTIVATED VACCINES 146
7.2.2.5 OTHERS 146
7.2.3 BIOLOGICS 147
7.2.3.1 MARKETED 147
7.2.3.1.1 TOCERANIB 148
7.2.3.1.2 LOMUSTINE 148
7.2.3.1.3 CYCLOPHOSPHAMIDE 148
7.2.3.1.4 CHLORAMBUCIL 148
7.2.3.1.5 OTHERS 148
7.2.3.2 EMERGING 148
7.2.4 MEDICATED FEED ADDITIVES 149
7.2.4.1 ENZYMES 150
7.2.4.1.1 PHYTASE 151
7.2.4.1.2 CARBOHYDRASE 151
7.2.4.1.3 PROTEASE 151
7.2.4.1.4 AMYLASE 151
7.2.4.1.5 CELLULASE 151
7.2.4.1.6 MANNASE 151
7.2.4.1.7 GLUCANASE 151
7.2.4.1.8 XYLANASE 151
7.2.4.1.9 OTHERS 151
7.2.4.2 AMINO ACID 152
7.2.4.2.1 LYSINE 152
7.2.4.2.2 METHIONINE 152
7.2.4.2.3 THREONINE 152
7.2.4.2.4 TRYPTOPHAN 152
7.2.4.2.5 OTHERS 152
7.2.4.3 VITAMINS 153
7.2.4.3.1 FAT-SOLUBLE VITAMIN 153
7.2.4.3.1.1 VITAMIN A 154
7.2.4.3.1.2 VITAMIN E 154
7.2.4.3.1.3 VITAMIN D 154
7.2.4.3.1.4 VITAMIN K 154
7.2.4.3.2 WATER-SOLUBLE VITAMIN 154
7.2.4.3.2.1 VITAMIN B COMPLEX 154
7.2.4.3.2.2 VITAMIN C 154
7.2.4.4 ANTIOXIDANTS 155
7.2.4.4.1 BHA 155
7.2.4.4.2 BHT 155
7.2.4.4.3 ETHOXYQUIN 155
7.2.4.4.4 OTHERS 155
7.2.4.5 PROBIOTICS 156
7.2.4.6 LACTOBACILLI 156
7.2.4.7 BIFIDOBACTERIA 156
7.2.4.8 YEAST 156
7.2.4.9 STRETOCOCCUS THERMOPHILUS 156
7.2.4.10 FEED ACIDIFIERS 157
7.2.4.10.1 PROPIONIC ACID 157
7.2.4.10.2 FORMIC ACID 157
7.2.4.10.3 LACTIC ACID 157
7.2.4.10.4 CITRIC ACID 157
7.2.4.10.5 OTHERS 157
7.2.4.11 MYCOTOXIN DETOXIFIERS 158
7.2.4.11.1 MYCOTOXIN BINDERS 158
7.2.4.11.1.1 SILICATES 159
7.2.4.11.1.2 CLAYS 159
7.2.4.11.1.3 CHEMICAL POLYMERS 159
7.2.4.11.1.4 GLUCAN PRODUCTS 159
7.2.4.11.1.5 OTHERS 159
7.2.4.11.2 MYCOTOXIN MODIFIERS 159
7.2.4.12 PHYTOGENIC 160
7.2.4.12.1 ESSENTIAL OILS 160
7.2.4.12.2 HERBS & SPICES 160
7.2.4.12.3 OLEORESIN 160
7.2.4.12.4 OTHERS 160
7.2.4.13 CAROTENOIDS 161
7.2.4.13.1 BETA-CAROTENE 161
7.2.4.13.2 ASTAXANTHIN 161
7.2.4.13.3 LUTEIN 161
7.2.4.13.4 CANTHAXANTHIN 161
7.2.4.14 TRACE MINERALS 162
7.2.4.14.1 ZINC 162
7.2.4.14.2 COPPER 162
7.2.4.14.3 MANGANESE 162
7.2.4.14.4 IRON 162
7.2.4.14.5 SELENIUM 162
7.2.4.14.6 OTHERS 162
7.2.4.15 PRESERVATIVES 163
7.2.4.15.1 ANTICAKING AGENTS 163
7.2.4.15.2 MOLD INHIBITORS 163
7.2.4.16 FLAVOURS AND SWEETENERS 164
7.2.4.16.1 FLAVORS 164
7.2.4.16.2 SWEETENERS 164
7.2.4.16.2.1 SACCHARIN 165
7.2.4.16.2.2 NEOHESPERIDIN DIHYDROCHALCONE 165
7.2.4.16.2.3 GLYCYRRHIZIN 165
7.2.4.16.2.4 THAUMATIN 165
7.2.4.16.2.5 OTHERS 165
7.2.4.17 OTHERS 165
7.3 DIAGNOSTICS 166
7.3.1 INSTRUMENTS & DEVICES 167
7.3.1.1 IMAGING DEVICES 167
7.3.1.2 X-RAY IMAGING (RADIOGRAPHY) 168
7.3.1.2.1 SMALL ANIMALS 168
7.3.1.2.2 LARGE ANIMALS 168
7.3.1.3 ULTRASOUND 168
7.3.1.3.1 SMALL ANIMALS 168
7.3.1.3.2 LARGE ANIMALS 168
7.3.1.4 COMPUTED TOMOGRAPHY 169
7.3.1.4.1 SMALL ANIMALS 169
7.3.1.4.2 LARGE ANIMALS 169
7.3.1.5 MAGNETIC RESONANCE IMAGING 169
7.3.1.5.1 SMALL ANIMALS 169
7.3.1.5.2 LARGE ANIMALS 169
7.3.1.6 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 170
7.3.1.6.1 SMALL ANIMALS 170
7.3.1.6.2 LARGE ANIMALS 170
7.3.1.6.3 OTHERS 170
7.3.2 LABORATORY INSTRUMENTS 171
7.3.2.1 HEMATOLOGY ANALYZERS 172
7.3.2.1.1 BY MODE 172
7.3.2.1.1.1 AUTOMATIC 172
7.3.2.1.1.2 SEMI-AUTOMATIC 172
7.3.2.1.2 BY PRICE RANGE 172
7.3.2.1.2.1 HIGH PRICE RANGE 172
7.3.2.1.2.2 STANDARD PRICE RANGE 172
7.3.2.1.3 BY MODALITY, 173
7.3.2.1.3.1 BENCHTOP 173
7.3.2.1.3.2 PORTABLE 173
7.3.2.1.3.3 OTHERS 173
7.3.2.2 CHEMISTRY ANALYZERS 174
7.3.2.2.1 BY MODE 174
7.3.2.2.1.1 AUTOMATIC 174
7.3.2.2.1.2 SEMI-AUTOMATIC 174
7.3.2.2.2 BY MODALITY, 174
7.3.2.2.2.1 BENCHTOP 174
7.3.2.2.2.2 PORTABLE 174
7.3.2.2.3 BY SAMPLE TYPE, 175
7.3.2.2.3.1 BLOOD 175
7.3.2.2.3.2 URINE 175
7.3.2.2.3.3 STOOL 175
7.3.2.2.3.4 OTHERS 175
7.3.2.3 POINT-OF-CARE INSTRUMENTS 176
7.3.2.3.1 BY TYPE 176
7.3.2.3.1.1 LATERAL FLOW POCT 176
7.3.2.3.1.2 MOLECULAR POCT 176
7.3.2.3.1.3 OTHERS 176
7.3.2.3.2 BY MODE 177
7.3.2.3.2.1 AUTOMATIC 177
7.3.2.3.2.2 SEMI-AUTOMATIC 177
7.3.2.4 COAGULATION ANALYZERS 177
7.3.2.4.1 BY CHANNEL, 178
7.3.2.4.1.1.1 4-CHANNEL 178
7.3.2.4.1.1.2 1-CHANNEL 178
7.3.2.4.2 BY SAMPLE TYPE 178
7.3.2.4.2.1 WHOLE BLOOD 178
7.3.2.4.2.2 PLASMA 178
7.3.2.4.3 BY MODALITY, 179
7.3.2.4.3.1 BENCHTOP 179
7.3.2.4.3.2 PORTABLE 179
7.3.2.5 URINALYSIS EQUIPMENT 180
7.3.2.5.1 BY MODE 180
7.3.2.5.1.1 AUTOMATIC 180
7.3.2.5.1.2 SEMI-AUTOMATIC 180
7.3.2.6 REFRACTOMETER 180
7.3.2.6.1 BY MODE, 180
7.3.2.6.1.1 OPTICAL 181
7.3.2.6.1.2 DIGITAL 181
7.3.2.6.2 BY MODALITY, 181
7.3.2.6.2.1 BENCHTOP 181
7.3.2.6.2.2 PORTABLE 181
7.3.2.7 OTHERS 181
7.3.3 REAGENTS & CONSUMABLES 182
7.3.3.1 KITS 183
7.3.3.1.1 PCR KITS 183
7.3.3.1.2 RAPID TEST KITS 183
7.3.3.1.3 MULTIPLEX KITS 183
7.3.3.1.4 ELISA KITS 183
7.3.3.1.5 SAMPLE PREPARATION KITS ISOLATION AND EXTRACTION KITS 183
7.3.3.1.6 OTHERS 183
7.3.3.2 REAGENTS 184
7.3.3.2.1 NUCLEIC ACID EXTRACTION REAGENTS 184
7.3.3.2.2 IMMUNOFLUORESCENCE REAGENTS 184
7.3.3.2.3 COOMBS REAGENTS 184
7.3.3.2.4 OTHERS REAGENTS 184
7.3.4 MEDIA 184
7.3.5 PANEL 184
7.3.6 STRIPS 184
7.3.7 CASSETTE 184
7.3.8 CONTROL STANDARDS 184
7.3.9 PROBES AND PRIMER 184
7.3.10 OTHERS CONSUMABLE AND ACCESSORIES 184
8 ASIA-PACIFIC VETERINARY MEDICINE MARKET, BY APPLICATION 185
8.1 OVERVIEW 186
8.2 BACTERIAL DISEASES 190
8.2.1 PRODUCTION ANIMALS 190
8.2.2 COMPANION ANIMALS 190
8.3 CANINE ATOPIC DERMATITIS 191
8.3.1 COMPANION ANIMALS 191
8.3.2 PRODUCTION ANIMALS 191
8.4 HEMINTHES INFECTION 192
8.4.1 PRODUCTION ANIMALS 192
8.4.2 COMPANION ANIMALS 192
8.5 ANIMAL CANCER 193
8.5.1 COMPANION ANIMALS 193
8.5.2 PRODUCTION ANIMALS 193
8.6 FOOT AND MOUTH DISEASE 194
8.6.1 PRODUCTION ANIMALS 194
8.6.2 COMPANION ANIMALS 194
8.7 AUTOIMMUNE DISEASES 195
8.7.1 COMPANION ANIMALS 195
8.7.2 PRODUCTION ANIMALS 195
8.8 BLUETONGUE 196
8.8.1 PRODUCTION ANIMALS 196
8.8.2 COMPANION ANIMALS 196
8.9 OTHERS 197
8.9.1 COMPANION ANIMALS 197
8.9.2 PRODUCTION ANIMAL 197
9 ASIA-PACIFIC VETERINARY MEDICINE MARKET, BY ANIMAL TYPE 198
9.1 OVERVIEW 199
9.2 COMPANION ANIMALS 202
9.2.1 DOGS 203
9.2.2 CATS 203
9.2.3 HORSES 203
9.2.4 OTHERS 203
9.3 PRODUCTION ANIMAL 204
9.3.1 POULTRY 205
9.3.2 CATTLE 205
9.3.3 SWINE 205
9.3.4 FISH 205
9.3.5 SHEEP & GOATS 205
9.3.6 OTHERS 205
10 ASIA-PACIFIC VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL 206
10.1 OVERVIEW 207
10.2 RETAIL SALES 210
10.2.1 OFFLINE 211
10.2.1.1 HOSPITAL PHARMACY 211
10.2.1.2 RETAIL PHARMACY 211
10.2.2 ONLINE 212
10.2.2.1 E-COMMERCE PLATFORMS 212
10.2.2.2 COMPANY WEBSITE 212
10.2.2.3 OTHERS 212
10.3 DIRECT TENDER 213
10.4 OTHERS 214
11 ASIA-PACIFIC VETERINARY MEDICINE MARKET, BY END USER 215
11.1 OVERVIEW 216
11.2 VETERINARY HOSPITALS 220
11.2.1 PRIVATE 220
11.2.2 PUBLIC 220
11.2.3 VETERINARY HOSPITALS BY LEVEL 221
11.2.3.1 TIER 2 221
11.2.3.2 TIER 1 221
11.2.3.3 TIER 3 221
11.3 VETERINARY CLINICS 222
11.3.1 VETERINARY CLINICS BY TYPE 222
11.3.1.1 PUBLIC 222
11.3.1.2 PRIVATE 222
11.4 ANIMAL AND VETERINARY FARMS 223
11.5 REFERENCE LABORATORIES 224
11.6 ACADEMIC AND RESEARCH INSTITUTE 225
11.7 POINT-OF-CARE TESTING/IN-HOUSE TESTING 226
11.8 OTHERS 22712 ASIA-PACIFIC VETERINARY MEDICINE MARKET, BY REGION 228
12.1 ASIA-PACIFIC 230
12.1.1 CHINA 261
12.1.2 JAPAN 289
12.1.3 INDIA 317
12.1.4 AUSTRALIA 345
12.1.5 SOUTH KOREA 373
12.1.6 SINGAPORE 399
12.1.7 INDONESIA 423
12.1.8 MALAYSIA 447
12.1.9 THAILAND 471
12.1.10 PHILIPPINES 495
12.1.11 REST OF ASIA-PACIFIC 519
13 ASIA-PACIFIC VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE 520
13.1 COMPANY SHARE ANALYSIS: GLOBAL 520
14 SWOT ANALYSIS 521
15 COMPANY PROFILES 522
15.1 ZOETIS SERVICES LLC SERVICES LLC. 522
15.1.1 COMPANY SNAPSHOT 522
15.1.2 REVENUE ANALYSIS 523
15.1.3 COMPANY SHARE ANALYSIS 523
15.1.4 PRODUCT PORTFOLIO 523
15.1.5 RECENT DEVELOPMENT 524
15.2 MERCK KGAA 526
15.2.1 COMPANY SNAPSHOT 526
15.2.2 REVENUE ANALYSIS 526
15.2.3 COMPANY SHARE ANALYSIS 527
15.2.4 PRODUCT PORTFOLIO 527
15.2.5 RECENT DEVELOPMENT 529
15.3 ELANCO OR ITS AFFILIATES. OR ITS AFFILIATES 530
15.3.1 COMPANY SNAPSHOT 530
15.3.2 REVENUE ANALYSIS 530
15.3.3 COMPANY SHARE ANALYSIS 531
15.3.4 PRODUCT PORTFOLIO 531
15.3.5 RECENT DEVELOPMENT 533
15.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 534
15.4.1 COMPANY SNAPSHOT 534
15.4.2 COMPANY SHARE ANALYSIS 534
15.4.3 PRODUCT PORTFOLIO 535
15.4.4 RECENT DEVELOPMENT 536
15.5 IDEXX LABORATORIES, INC 538
15.5.1 COMPANY SNAPSHOT 538
15.5.2 REVENUE ANALYSIS 538
15.5.3 COMPANY SHARE ANALYSIS 539
15.5.4 PRODUCT PORTFOLIO 539
15.5.5 RECENT DEVELOPMENT 541
15.6 AB SCIENCE 542
15.6.1 COMPANY SNAPSHOT 542
15.6.2 REVENUE ANALYSIS 542
15.6.3 PRODUCT PORTFOLIO 543
15.6.4 RECENT DEVELOPMENT 543
15.7 ADVACARE PHARMA 544
15.7.1 COMPANY SNAPSHOT 544
15.7.2 PRODUCT PORTFOLIO 544
15.7.3 RECENT DEVELOPMENT 545
15.8 ALMAX IMAGING SRL 546
15.8.1 COMPANY SNAPSHOT 546
15.8.2 PRODUCT PORTFOLIO 546
15.8.3 RECENT DEVELOPMENT 546
15.9 ANIVIVE 547
15.9.1 COMPANY SNAPSHOT 547
15.9.2 PRODUCT PORTFOLIO 547
15.9.3 RECENT DEVELOPMENT 550
15.10 BIOMÉRIEUX 551
15.10.1 COMPANY SNAPSHOT 551
15.10.2 REVENUE ANALYSIS 551
15.10.3 PRODUCT PORTFOLIO 552
15.10.4 RECENT DEVELOPMENT 552
15.11 BIONOTE USA INC. 553
15.11.1 COMPANY SNAPSHOT 553
15.11.2 PRODUCT PORTFOLIO 553
15.11.3 RECENT DEVELOPMENT 556
15.12 BIO-RAD LABORATORIES, INC. 557
15.12.1 COMPANY SNAPSHOT 557
15.12.2 REVENUE ANALYSIS 557
15.12.3 PRODUCT PORTFOLIO 558
15.12.4 RECENT DEVELOPMENT 560
15.13 CANON MEDICAL SYSTEMS EUROPE B.V. 561
15.13.1 COMPANY SNAPSHOT 561
15.13.2 REVENUE ANALYSIS 561
15.13.3 PRODUCT PORTFOLIO 562
15.13.4 RECENT DEVELOPMENT 562
15.14 CARGIL INCORPORATED 563
15.14.1 COMPANY SNAPSHOT 563
15.14.2 PRODUCT PORTFOLIO 563
15.14.3 RECENT DEVELOPMENT 565
15.15 CEVA 566
15.15.1 COMPANY SNAPSHOT 566
15.15.2 PRODUCT PORTFOLIO 566
15.15.3 RECENT DEVELOPMENT 568
15.16 CURELAB ONCOLOGY 569
15.16.1 COMPANY SNAPSHOT 569
15.16.2 PRODUCT PORTFOLIO 569
15.16.3 RECENT DEVELOPMENT 570
15.17 DECHRA PHARMACEUTICALS LIMITED 571
15.17.1 COMPANY SNAPSHOT 571
15.17.2 REVENUE ANALYSIS 571
15.17.3 PRODUCT PORTFOLIO 572
15.17.4 RECENT DEVELOPMENT 574
15.18 DEMEDITEC DIAGNOSTICS GMBH 575
15.18.1 COMPANY SNAPSHOT 575
15.18.2 PRODUCT PORTFOLIO 575
15.18.3 RECENT DEVELOPMENT 577
15.19 DHN 578
15.19.1 COMPANY SNAPSHOT 578
15.19.2 PRODUCT PORTFOLIO 578
15.19.3 RECENT DEVELOPMENT 580
15.20 DIAGNOSTIC IMAGING SYSTEMS 582
15.20.1 COMPANY SNAPSHOT 582
15.20.2 PRODUCT PORTFOLIO 582
15.20.3 RECENT DEVELOPMENT 584
15.21 ESAOTE SPA 585
15.21.1 COMPANY SNAPSHOT 585
15.21.2 PRODUCT PORTFOLIO 585
15.21.3 RECENT DEVELOPMENT 587
15.22 EUROFINS SCIENTIFIC 588
15.22.1 COMPANY SNAPSHOT 588
15.22.2 REVENUE ANALYSIS 589
15.22.3 PRODUCT PORTFOLIO 589
15.22.4 RECENT DEVELOPMENT 590
15.23 EVONIK ANIMAL NUTRITION 591
15.23.1 COMPANY SNAPSHOT 591
15.23.2 REVENUE ANALYSIS 591
15.23.3 1.1.3 PRODUCT PORTFOLIO 592
15.23.4 RECENT DEVELOPMENT 593
15.24 FUJIFILM HOLDINGS CORPORATION 594
15.24.1 COMPANY SNAPSHOT 594
15.24.2 REVENUE ANALYSIS 594
15.24.3 PRODUCT PORTFOLIO 595
15.24.4 RECENT DEVELOPMENT 598
15.25 GOLD STANDARD DIAGNOSTICS 599
15.25.1 COMPANY SNAPSHOT 599
15.25.2 PRODUCT PORTFOLIO 599
15.25.3 RECENT DEVELOPMENT 601
15.26 HALLMARQ VETERINARY IMAGING 602
15.26.1 COMPANY SNAPSHOT 602
15.26.2 PRODUCT PORTFOLIO 602
15.26.3 RECENT DEVELOPMENT 603
15.27 HEBEI VEYONG PHARMACEUTICAL CO., LTD. 604
15.27.1 COMPANY SNAPSHOT 604
15.27.2 PRODUCT PORTFOLIO 604
15.27.3 RECENT DEVELOPMENT 608
15.28 IBIS S.R.L. 609
15.28.1 COMPANY SNAPSHOT 609
15.28.2 PRODUCT PORTFOLIO 609
15.28.3 RECENT DEVELOPMENT 611
15.29 VIRBAC 612
15.29.1 COMPANY SNAPSHOT 612
15.29.2 REVENUE ANALYSIS 613
15.29.3 PRODUCT PORTFOLIO 613
15.29.4 RECENT DEVELOPMENT 616
15.30 VMRD, INC 617
15.30.1 COMPANY SNAPSHOT 617
15.30.2 PRODUCT PORTFOLIO 617
15.30.3 RECENT DEVELOPMENT 619
15.31 HESKA CORPORATION 620
15.31.1 COMPANY SNAPSHOT 620
15.31.2 REVENUE ANALYSIS 620
15.31.3 PRODUCT PORTFOLIO 621
15.31.4 RECENT DEVELOPMENT 622
15.32 KARYOPHARM 623
15.32.1 COMPANY SNAPSHOT 623
15.32.2 REVENUE ANALYSIS 623
15.32.3 PRODUCT PORTFOLIO 624
15.32.4 RECENT DEVELOPMENT 624
15.33 MERIDIAN BIOSCIENCE, INC 625
15.33.1 COMPANY SNAPSHOT 625
15.33.2 PRODUCT PORTFOLIO 625
15.33.3 RECENT DEVELOPMENT 626
15.34 NARANG MEDICAL LIMITED 627
15.34.1 COMPANY SNAPSHOT 627
15.34.2 PRODUCT PORTFOLIO 627
15.34.3 RECENT DEVELOPMENT 631
15.35 NEOGEN CORPORATION 632
15.35.1 COMPANY SNAPSHOT 632
15.35.2 REVENUE ANALYSIS 632
15.35.3 PRODUCT PORTFOLIO 633
15.35.4 RECENT DEVELOPMENT 635
15.36 NIPPON ZENYAKU KOGYO CO., LTD. 636
15.36.1 COMPANY SNAPSHOT 636
15.36.2 PRODUCT PORTFOLIO 636
15.36.3 RECENT DEVELOPMENT 637
15.37 VETDC 638
15.37.1 COMPANY SNAPSHOT 638
15.37.2 PRODUCT PORTFOLIO 638
15.37.3 RECENT DEVELOPMENT 639
15.38 NOVAVIVE INC. 640
15.38.1 COMPANY SNAPSHOT 640
15.38.2 PRODUCT PORTFOLIO 640
15.38.3 RECENT DEVELOPMENT 642
15.39 NUTRECO 643
15.39.1 COMPANY SNAPSHOT 643
15.39.2 PRODUCT PORTFOLIO 643
15.39.3 RECENT DEVELOPMENT 644
15.40 PLANMECA OY 645
15.40.1 COMPANY SNAPSHOT 645
15.40.2 PRODUCT PORTFOLIO 645
15.40.3 RECENT DEVELOPMENT 647
15.41 RANDOX LABORATORIES LTD. 648
15.41.1 COMPANY SNAPSHOT 648
15.41.2 PRODUCT PORTFOLIO 648
15.41.3 RECENT DEVELOPMENT 650
15.42 RINGPU BIOLOGY CO., LTD. 651
15.42.1 COMPANY SNAPSHOT 651
15.42.2 PRODUCT PORTFOLIO 651
15.42.3 RECENT DEVELOPMENT 654
15.43 SHENZHEN SONTU MEDICAL IMAGING EQUIPMENT CO., LTD 655
15.43.1 COMPANY SNAPSHOT 655
15.43.2 PRODUCT PORTFOLIO 655
15.43.3 RECENT DEVELOPMENT 657
15.44 THERMO FISHER SCIENTIFIC INC 658
15.44.1 COMPANY SNAPSHOT 658
15.44.2 REVENUE ANALYSIS 659
15.44.3 PRODUCT PORTFOLIO 659
15.44.4 RECENT DEVELOPMENT 660
15.45 TORIGEN PHARMACEUTICALS INC. 661
15.45.1 COMPANY SNAPSHOT 661
15.45.2 PRODUCT PORTFOLIO 661
15.45.3 RECENT DEVELOPMENT 662
16 QUESTIONNAIRE 663
17 RELATED REPORTS 666